Press

Newsroom

Contact
press@imprimedicine.com
Follow
Download
Press Kit

Featured articles

ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
TechCrunch

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
USA Today

ImpriMed’s Transformative, Personal Approach to Canine Cancer Treatment

Read More →
ImpriMed is Revolutionizing Canine Cancer Treatment with Precision and Personalization
International Business Times

ImpriMed: Revolutionizing Canine Cancer Treatment with Precision and Personalization

Read More →
Meet ImpriMed, Mayo Clinic just welcomed to its AI accelerator program
MedCity News

Meet the 7 startups Mayo Clinic just welcomed to its AI accelerator

Read More →

Latest Stories

Button Text
In the News
Button Text
Presentations
Button Text
Press Releases
Button Text
Scientific Publications
Button Text
Video/Podcast Interviews
In the News
Ideamensch logo

Interview with ImpriMed CEO & Co-Founder Sungwon Lim

IdeaMensch
Learn More →
Video/Podcast Interviews
Scott Amyx logo

Interview with Dr. Sungwon Lim, CEO of ImpriMed

Innovating with Scott Amyx
Learn More →
Video/Podcast Interviews
Insivia Logo

Tech Founder Interview with Sungwon Lim, CEO & Founder of ImpriMed

Tech Founder Show by Insivia
Learn More →
Press Releases
EIN Presswire logo

ImpriMed Initiates Feline Lymphoma Drug Response Prediction Study

EIN Presswire
Learn More →
In the News
Canine Cancer Alliance logo

This Test Might Make All The Difference When Fighting Lymphoma

Canine Cancer Alliance
Learn More →
Press Releases
Globenewswire logo

ImpriMed Launches Chemo Response Prediction and Immunophenotyping Services for Canine Lymphoma

GlobeNewswire
Learn More →
Press Releases
GlobeNewswire Logo

ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in Pet Cancer Market

GlobeNewswire
Learn More →
In the News
Startup Thread logo

ImpriMed: Fighting Cancer — From Dogs To Humans

Startup Thread
Learn More →
Press Releases
PR Underground logo

ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers

PR Underground
Learn More →
Video/Podcast Interviews
Canine Cancer Alliance logo

Which Drugs Can Kill Your Dog's Cancer Cells? - ImpriMed's Sungwon Lim | Canine Cancer Rebel

Canine Cancer Alliance
Learn More →
Presentations
Veterinary Cancer Society Logo

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary Cancer Society Annual Conference 2020
Learn More →
Presentations
Veterinary Cancer Society logo

ImpriMed: A data-driven, personalized chemotherapy drug testing service for canine blood cancer patients

Veterinary Cancer Society Annual Conference 2021
Learn More →
Scientific Publications
Veterinary and Comparative Oncology logo

Predicting likelihood of in vivo chemotherapy response in canine lymphoma using ex vivo drug sensitivity and immunophenotyping data in a machine learning model

Veterinary and Comparative Oncology
Learn More →
Presentations
World Veterinary Cancer Congress logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

World Veterinary Cancer Congress 2020
Learn More →
Presentations
Precision Medicine World Conference logo

From dog to human: precision medicine for comparative oncology

Precision Medicine World Conference 2020
Learn More →
Video/Podcast Interviews
Rodrigo Flamenco Logo

Interview with Sungwon Lim: Founder & CEO of ImpriMed

Entrepreneurship, Interviews, Level Up!
Learn More →
Presentations
NYC Oncology Conference 2019

ImpriMed: precision medicine for pet cancer care

NYC Oncology Conference 2019
Learn More →
Presentations
Veterinary Cancer Society Logo

Individualizing chemotherapy for canine lymphoma based on ex vivo drug sensitivity test

Veterinary Cancer Society Annual Conference 2019
Learn More →